Clinical Trial Update: The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients [NA]

View source ↗

Summary

The trial investigates the role of DNA and RNA sequencing in NGS analyses for advanced-stage non-small cell lung cancer. Recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Non Small Cell Lung Cancer NSCLC | NA | Status: RECRUITING